Safety and efficacy of G-CSF mobilization and collection of autologous peripheral blood stem cells in children with cerebral palsy

Transfus Apher Sci. 2013 Dec;49(3):516-21. doi: 10.1016/j.transci.2013.08.003. Epub 2013 Aug 24.

Abstract

We hypothesized that mobilized peripheral blood stem cells (PBSCs) could be useful for treating neurological impairments and therefore assessed the safety of administering G-CSF followed by collecting PBSC in children with cerebral palsy (CP). G-CSF (10 μg/kg/day) was administered subcutaneously for 5 days, and apheresis was performed to collect PBSC via central venous catheter. G-CSF-related events occurred in 3 patients (fever in 2, irritability in 1). No catheter-related complications were reported. None of the patients needed platelet transfusion or calcium replacement during apheresis. Mobilization with G-CSF followed by PBSC collection appears to be safe and feasible in CP children.

Keywords: Apheresis; Cerebral palsy; G-CSF; Peripheral blood stem cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Component Removal / methods*
  • Cerebral Palsy / blood*
  • Cerebral Palsy / surgery
  • Child
  • Child, Preschool
  • Female
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Granulocyte Colony-Stimulating Factor / adverse effects
  • Hematopoietic Stem Cell Mobilization / methods*
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Male
  • Transplantation, Autologous

Substances

  • Granulocyte Colony-Stimulating Factor